Skip to NavigationSkip to content

News

Bristol-Myers Squibb to sell of Celgene's Otezla ahead of $74 billion merger
Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators.
Pfizer's Talzenna approved in Europe for HER2- advanced breast cancer with gBRCA1/2 mutations
Pfizer’s Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker has confirmed, as a monotherapy for the...
Glenmark signs deal with Novartis over distribution in Brazil
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil.
FDA expands Vertex's cystic fibrosis drug Symdeko in paediatric patients
Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko.
>> More News Stories

Features

The Brexit ‘cliff edge’: How life sciences can survive

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit appears as an...

>> More Features

Appointments

GSK tech exec joins Institute of Cancer Research

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information Officer....

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches